SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of Sinovac Biotech Ltd. to Sinovac (Cayman) Limited and Sinovac Amalgamation Sub Limited for $7.00 Per Share is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Sinovac Biotech Ltd. (NASDAQ:SVA) stock prior to June 26, 2017.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Sinovac to Sinovac (Cayman) Limited and Sinovac Amalgamation Sub Limited for US$7.00 per share. As of June 23, 2017, the buyers own approximately 29.5% of the issued and outstanding shares of Sinovac. To learn more about the action and your rights, go to:

http://www.zlkdocs.com/SVA-Info-Request-Form-ma-5898

or contact Joseph E. Levi, Esq. either via email at [e-mail] or by telephone at [phone], toll-free: [phone]. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: [phone]
Toll Free: [phone]
Fax: [phone]
www.zlk.com